Evaluation of Hypoglycemic and Anti-Hyperglycemic Potential of Tridax Procumbens (Linn.)

    Hemant Pareek, Sameer Sharma, Balvant S. Khajja, Kusum Jain, GC Jain
    Studysummary This study supports the traditional use of T. procumbens for diabetes treatment, showing improvements in body weight and glucose tolerance with no toxicity signs in normal rats. Our plain-language summary of this paper — not a Tressless recommendation.
    The study investigated the hypoglycemic and anti-hyperglycemic effects of Tridax procumbens in diabetic rats, using a methanolic extract at doses of 250 and 500 mg/kg. The extract significantly reduced fasting blood glucose levels, with a maximum reduction of over 68% within 6 hours, surpassing the effects of the standard drug Glibenclamide. It improved body weight and glucose tolerance in diabetic rats without affecting normal rats, indicating its specific action in diabetic conditions and a high safety margin. The study supported the traditional use of T. procumbens for diabetes treatment and suggested further research to isolate its active constituents.
    Discuss this study in the Community →